Pnc Financial Services Group, Inc. Summit Therapeutics Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 520 shares of SMMT stock, worth $12,797. This represents 0.0% of its overall portfolio holdings.
Number of Shares
520
Previous 470
10.64%
Holding current value
$12,797
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SMMT
# of Institutions
231Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$601 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$287 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$194 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$161 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$138 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.95B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...